APA (7th ed.) Citation

S, A., AP, P., M, S., D, W., A, P., E, L., . . . M, T. (2024). APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics. Alzheimer's & dementia (New York, N. Y.), 10(3), e12498. https://doi.org/10.1002/trc2.12498

Chicago Style (17th ed.) Citation

S, Abushakra, et al. "APOLLOE4 Phase 3 Study of Oral ALZ-801/valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer's Disease: Trial Design and Baseline Characteristics." Alzheimer's & Dementia (New York, N. Y.) 10, no. 3 (2024): e12498. https://doi.org/10.1002/trc2.12498.

MLA (9th ed.) Citation

S, Abushakra, et al. "APOLLOE4 Phase 3 Study of Oral ALZ-801/valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer's Disease: Trial Design and Baseline Characteristics." Alzheimer's & Dementia (New York, N. Y.), vol. 10, no. 3, 2024, p. e12498, https://doi.org/10.1002/trc2.12498.